Accession Number: | 0001645113-20-000096 |
Date: | 2020-07-07 |
Issuer: | NOVOCURE LTD (NVCR) |
Original Submission Date: |
SHAH PRITESH
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-07-07 | A | 325 | a | $50.41 | 101,018 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the novocure limited employee share purchase plan ("espp"), for the espp purchase period of january 1, 2020 through june 30, 2020. this transaction is also exempt under rule 16b-3(c). |
f2 | in accordance with the espp, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on june 30, 2020. |